Sandbox g53

• HHV-7 Return to Top

• Most patients with infection with HHV-7 will be asymptomatic. It is unknown whether treatment in asymptomatic patients will lead to a reduction in subsequent infection. (15504215)
• Immunocompetent hosts with uncomplicated skin manifestations associated with HHV-7, particularly roseola infantum and pityriasis rosea, need only symptomatic management. (22819486)
• For HIV-positive patients, antiretroviral therapy may be advisable. (sanford)
• There are no defined circumstances that warrant specific antiviral therapy for HHV-7. (10578120)
• The most active antiviral compounds against HHV-7 are Cidofovir and Foscarnet. (11747000)